v3.22.4
Revenue Recognition - Summary of Disaggregation of Revenue by Product Platform/Type (Detail) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Revenue $ 56,902 $ 88,341
Revenue, % change (36.00%)  
Diagnostics [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 39,366 33,204
Revenue, % change 19.00%  
Diagnostics [Member] | Molecular Assays [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 4,490 4,752
Revenue, % change (6.00%)  
Diagnostics [Member] | Non-molecular assays    
Segment Reporting Information [Line Items]    
Revenue $ 34,876 28,452
Revenue, % change 23.00%  
Life Science [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 17,536 55,137
Revenue, % change (68.00%)  
Life Science [Member] | Molecular Reagents [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 7,574 31,488
Revenue, % change (76.00%)  
Life Science [Member] | Immunological Reagents [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 9,962 $ 23,649
Revenue, % change (58.00%)